MedPath

FLOVENT DISKUS

FLOVENT DISKUS

Approved
DIN Number

02237245

Drug Class

Human

Market Date

Apr 2, 1998

Company
HC

GlaxoSmithKline Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02237245
AIG Number0124685007
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03BA05 FLUTICASONE
Product Specifications
Dosage FormPowder
Route of AdministrationInhalation
AHFS Classification68:04.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

FLUTICASONE PROPIONATEActive
Strength: 100 MCG / ACT
Monograph: FLUTICASONE PROPIONATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.